Pharma & Biotech

The investment landscape for Intellia Therapeutics has grown increasingly turbulent. A recent fatality within one of the company's clinical trials...

PDS Biotechnology Corp witnessed a sharp decline in its share price following the announcement of a new financing arrangement designed...

IQVIA Holdings Inc. has delivered a powerful performance in its latest quarterly report, exceeding market projections and reinforcing its strategic...

Investors in the telemedicine platform Hims & Hers are facing a complex investment landscape. While the company continues to demonstrate...

Biotechnology firm Inovio Pharmaceuticals has triggered investor alarm with a deeply discounted stock offering that aims to secure crucial funding....

The stock performance of artificial intelligence healthcare company Tempus AI has become a focal point for investor debate this year....

Biotechnology firm Altimmune is witnessing a substantial rally in its share price following the release of impressive mid-stage clinical trial...

Biopharmaceutical firm Ocugen presents investors with a classic dilemma: promising clinical developments in gene therapy set against a backdrop of...

Genetic testing specialist Natera has delivered a quarterly report that significantly surpassed market forecasts, propelling its stock upward. The company...

Pharmaceutical giant Eli Lilly has made a decisive move in its corporate benefits strategy, immediately dropping CVS Health as its...